trial vaccine
The Latest
-
2 COVID-19 Drugs From Lilly May Be Cleared For Use As Early As September
Eli Lilly to start dosing COVID-19 patients in complementary Phase 1 Study in the US in the next coming days. 
Eli Lilly to start dosing COVID-19 patients in complementary Phase 1 Study in the US in the next coming days. -
WHO Reports 3 Of 70 Coronavirus Vaccines Currently Undergoing Human Testing
Beijing Institute of Biotechnology, in tandem with CanSino Bio of Hong Kong, leads the charge with their own Ad5-nCoV vaccine 
Beijing Institute of Biotechnology, in tandem with CanSino Bio of Hong Kong, leads the charge with their own Ad5-nCoV vaccine
